Polaryx Therapeutics PLYX
NASDAQ PLYX
$2.03 +0.01 (+0.50%)
As of: Oct 2, 2026 · 10:29 AM EDT

Polaryx Therapeutics (PLYX) EBIT (2025 - 2026)

Updated

Polaryx Therapeutics (PLYX) posted EBIT of -$1.38 million for Q2 2026, compared with -$884,000 a year earlier.

Analysis

Polaryx Therapeutics (PLYX) EBIT (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EBIT at Polaryx Therapeutics was -$9.27 million; for FY2025, it was -$7.82 million.

  • In prior years, Polaryx Therapeutics' EBIT was -$4.35 million in FY2024.
  • Quarterly EBIT has run from a low of -$5.05 million in Q1 2025 to a high of -$884,000 in Q2 2025 over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 7.14 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 6.43 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 3.16 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -10.39 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Polaryx Therapeutics 103.18 Mn 78.80 Mn - -1.38 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -1.38 Mn
Mar 31, 2026 -1.96 Mn
Jun 30, 2025 -884,000.00
Mar 31, 2025 -5.05 Mn
API Access

Polaryx Therapeutics EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=PLYX&period=max&api_key=YOUR_API_KEY